Acquisition by Matthew Lustig of 560 shares of Ventas at 57.96 subject to Rule 16b-3
| VTR Stock | USD 56.90 1.41 2.42% |
Slightly above 61% of Ventas' investor base is looking to short. The analysis of overall sentiment of trading Ventas Inc stock suggests that many investors are alarmed at this time. Ventas' investing sentiment overview a quick insight into current market opportunities from investing in Ventas Inc. Many technical investors use Ventas Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Ventas |
Filed transaction by Ventas Inc Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Ventas Fundamental Analysis
We analyze Ventas' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ventas using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ventas based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earnings To Growth
Price To Earnings To Growth Comparative Analysis
Ventas is currently under evaluation in price to earnings to growth category among its peers. PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Ventas Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ventas stock to make a market-neutral strategy. Peer analysis of Ventas could also be used in its relative valuation, which is a method of valuing Ventas by comparing valuation metrics with similar companies.
Peers
Ventas Related Equities
| HR | Healthcare Realty | 0.61 | ||||
| UHT | Universal Health | 0.41 | ||||
| GMRE | Global Medical | 0.78 | ||||
| CTRE | CareTrust REIT | 1.35 | ||||
| DOC | Healthpeak Properties | 1.96 | ||||
| OHI | Omega Healthcare | 2.66 | ||||
| NHI | National Health | 3.12 | ||||
| SBRA | Sabra Healthcare | 3.65 |
Additional Tools for Ventas Stock Analysis
When running Ventas' price analysis, check to measure Ventas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventas is operating at the current time. Most of Ventas' value examination focuses on studying past and present price action to predict the probability of Ventas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventas' price. Additionally, you may evaluate how the addition of Ventas to your portfolios can decrease your overall portfolio volatility.